The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A multicenter, randomized, open-label, phase 2 study of carfilzomib with or without ARRY-520 (filanesib) in patients with advanced multiple myeloma.
 
Jeffrey A. Zonder
Honoraria - Prothena
Consulting or Advisory Role - Array BioPharma; Bristol-Myers Squibb; Celgene; Prothena
Research Funding - Celgene
Other Relationship - Pharmacyclics
 
Noopur S. Raje
Consulting or Advisory Role - Amgen; Celgene; Millennium; Onyx
Research Funding - Acetylon Pharmaceuticals; Lilly
 
Emma Catherine Scott
Consulting or Advisory Role - Millennium; Onyx
Speakers' Bureau - Millennium
Research Funding - Millennium; Onyx
 
Craig C. Hofmeister
Honoraria - Millennium
Consulting or Advisory Role - Onyx
Speakers' Bureau - Celgene
Research Funding - Arno Therapeutics; Celgene; Merck; Millennium
Patents, Royalties, Other Intellectual Property - N/A (Inst)
Travel, Accommodations, Expenses - Celgene
 
Nikoletta Lendvai
No Relationships to Disclose
 
Larry Don Anderson
Speakers' Bureau - Celgene; Millennium; Onyx
 
Parameswaran Hari
Stock and Other Ownership Interests - Pharmacyclics
Honoraria - Celgene; Millennium; Onyx; Sanofi
Consulting or Advisory Role - Celgene; Millennium; Onyx; Sanofi
Research Funding - Celgene (Inst); Millennium (Inst)
 
Gregory Joshua Orloff
No Relationships to Disclose
 
Jesus G. Berdeja
Research Funding - Bristol-Myers Squibb; Celgene; MEI Pharma; Onyx; Takeda
 
Seema Singhal
Stock and Other Ownership Interests - Celgene; Celldex; eHealth; Epizyme; Foundation Medicine; Geron; GlaxoSmithKline; Immunogen; Nanosphere; Panther Biotechnology; Pfizer; Pharmacyclics; Sarepta Therapeutics; Seagen; Signal Genetics; Synta; Vertex
Speakers' Bureau - Celgene; Millennium
 
Michael Craig
No Relationships to Disclose
 
Jason Neil Valent
Speakers' Bureau - Celgene; Millennium
 
Mieke Ptaszynski
Employment - Array BioPharma
Stock and Other Ownership Interests - Array BioPharma
 
Jennifer Schreiber
Employment - Array BioPharma
Stock and Other Ownership Interests - Array BioPharma
 
Roger Aitchison
Employment - Array BioPharma
Stock and Other Ownership Interests - Array BioPharma
 
Saad Zafar Usmani
Consulting or Advisory Role - Celgene; Millennium; Onyx; Sanofi
Speakers' Bureau - Celgene; Millennium; Onyx
Research Funding - Array BioPharma; Celgene; Janssen Oncology; Millennium; Onyx; Pharmacyclics